Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $13.1 billion.

  • Fresenius Medical Care AG's Total Non-Current Liabilities rose 94.52% to $13.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 billion, marking a year-over-year increase of 94.52%. This contributed to the annual value of $13.0 billion for FY2024, which is 720.38% down from last year.
  • Fresenius Medical Care AG's Total Non-Current Liabilities amounted to $13.1 billion in Q3 2025, which was up 94.52% from $12.8 billion recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Total Non-Current Liabilities registered a high of $15.5 billion during Q1 2022, and its lowest value of $12.4 billion during Q1 2025.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $14.6 billion (2023), whereas its average is $14.3 billion.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Total Non-Current Liabilities surged by 1388.49% in 2021, and later tumbled by 1223.81% in 2025.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Total Non-Current Liabilities stood at $15.0 billion in 2021, then decreased by 6.01% to $14.1 billion in 2022, then dropped by 0.99% to $14.0 billion in 2023, then decreased by 7.2% to $13.0 billion in 2024, then increased by 1.12% to $13.1 billion in 2025.
  • Its last three reported values are $13.1 billion in Q3 2025, $12.8 billion for Q2 2025, and $12.4 billion during Q1 2025.